Bio Green Med Solution is trading 6.85% down at $0.86 amid broader-market weakness, though no direct cause for the stock’s October 14 decline has been confirmed. - No company-specific announcement explaining the decline was confirmed; market data showed no company headlines on October 14. The latest listed company release was August 12. - Hotter-than-expected September inflation revived concerns about higher interest rates; the S&P 500 fell 0.66% and the Nasdaq Composite fell 0.89%.